Therefore, increased expression and/or activity of endothelial NOS or DDAH using selective NCEs is a novel strategy to develop effective insulin sensitizers that are also expected to protect the vascular wall and reduce major adverse cardiovascular events including stroke and heart attack. This evidence concerns the gene DDAH2 and Stroke.